These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31964469)

  • 81. Desoxyrhapontigenin inhibits RANKL‑induced osteoclast formation and prevents inflammation‑mediated bone loss.
    Tran PT; Park DH; Kim O; Kwon SH; Min BS; Lee JH
    Int J Mol Med; 2018 Jul; 42(1):569-578. PubMed ID: 29693149
    [TBL] [Abstract][Full Text] [Related]  

  • 82. (-)-Epigallocatechin-3-gallate inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing NF-κB and MAPK signaling pathways.
    Xu H; Liu T; Jia Y; Li J; Jiang L; Hu C; Wang X; Sheng J
    Int Immunopharmacol; 2021 Jun; 95():107464. PubMed ID: 33677256
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Osthole inhibits osteoclasts formation and bone resorption by regulating NF-κB signaling and NFATc1 activations stimulated by RANKL.
    Ma Y; Wang L; Zheng S; Xu J; Pan Y; Tu P; Sun J; Guo Y
    J Cell Biochem; 2019 Sep; 120(9):16052-16061. PubMed ID: 31081953
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pyridone 6, a pan-Janus-activated kinase inhibitor, suppresses osteoclast formation and bone resorption through down-regulation of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand (RANKL)-induced c-Fos and nuclear factor of activated T cells (NFAT) c1 expression.
    Kwak HB; Kim HS; Lee MS; Kim KJ; Choi EY; Choi MK; Kim JJ; Cho HJ; Kim JW; Bae JM; Kim YK; Park BH; Ha H; Chun CH; Oh J
    Biol Pharm Bull; 2009 Jan; 32(1):45-50. PubMed ID: 19122279
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Platycodin D Inhibits Osteoclastogenesis by Repressing the NFATc1 and MAPK Signaling Pathway.
    Choi JH; Han Y; Kim YA; Jin SW; Lee GH; Jeong HM; Lee HS; Chung YC; Lee YC; Kim EJ; Lee KY; Jeong HG
    J Cell Biochem; 2017 Apr; 118(4):860-868. PubMed ID: 27739107
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dynein light chain LC8 inhibits osteoclast differentiation and prevents bone loss in mice.
    Kim H; Hyeon S; Kim H; Yang Y; Huh JY; Park DR; Lee H; Seo DH; Kim HS; Lee SY; Jeong W
    J Immunol; 2013 Feb; 190(3):1312-8. PubMed ID: 23293355
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
    Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
    Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
    Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss.
    Kim HJ; Kim BK; Ohk B; Yoon HJ; Kang WY; Cho S; Seong SJ; Lee HW; Yoon YR
    J Cell Physiol; 2019 Feb; 234(2):1659-1670. PubMed ID: 30076703
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways.
    Lee SH; Park SY; Kim JH; Kim N; Lee J
    BMB Rep; 2023 Oct; 56(10):551-556. PubMed ID: 37605614
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-κB, c-Fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway.
    Huh JE; Lee WI; Kang JW; Nam D; Choi DY; Park DS; Lee SH; Lee JD
    J Nat Prod; 2014 Nov; 77(11):2423-31. PubMed ID: 25397676
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression.
    Kim EJ; Lee H; Kim MH; Yang WM
    BMC Complement Altern Med; 2018 Oct; 18(1):270. PubMed ID: 30285722
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Chitooligosaccharide inhibits RANKL-induced osteoclastogenesis and ligation-induced periodontitis by suppressing MAPK/ c-fos/NFATC1 signaling.
    Xu W; Chen X; Wang Y; Fan B; Guo K; Yang C; Yu S; Pang Y; Zhang S
    J Cell Physiol; 2020 Mar; 235(3):3022-3032. PubMed ID: 31541460
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway.
    Ren LR; Wang ZH; Wang H; He XQ; Song MG; Xu YQ
    Med Sci Monit; 2017 Sep; 23():4579-4590. PubMed ID: 28942456
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
    Kim HJ; Lee J; Lee GR; Kim N; Lee HI; Kwon M; Kim NY; Park JH; Kang YH; Song HJ; Kim T; Shin DM; Jeong W
    J Cell Physiol; 2021 Dec; 236(12):8239-8252. PubMed ID: 34192358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.